国控、上药、华润、九州通,四大千亿药商业绩大比拼!

MedTrend医趋势
03 May

四大药商最新业绩全部出炉。01四大药商营收增速放缓两家净利润率回升2024年,头部四大药商中有三家都实现了营收增长,其中,上药营收规模首次突破2700亿元,达到2752.5亿元,华润达到2576.7亿元,九州通也在2023年突破1500亿元“关口”的基础上进一步增长至1518亿元。不过,三者在增速方面均呈现放缓趋势,上药和华润营收增幅均从2023年的12%左右降至2024年的5%左右,九州通从近...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10